Pneumococcal and influenza immunization in asplenic persons: A retrospective population-based cohort study 1990-2002

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Langley, Joanne M ^a,b   Dodds, Linda ^a,b   Fell, Deshayne ^b   Langley, G Ross ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; ASPLENIA; COHORT ANALYSIS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNIZATION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCOCCAL INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SPLENECTOMY; ADOLESCENT; CHILD; IMMUNOLOGY; LONGITUDINAL STUDY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; SPLENECTOMY; YOUNG ADULT;

EID: 77954786625     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-219     Document Type: Article

References (33)

1. Lutwick LI. Life threatening infections in the asplenic or hyposplenic individual. Curr Clin Top Infect Dis 2002, 22:78-96.
2. Spelman D, Buttery J, Daley A, Isaacs D, Jennens I, Kakakios A, Lawrence R, Roberts S, Torda A, Watson DA, et al. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients. Intern Med J 2008, 38(5):349-356. 10.1111/j.1445-5994.2007.01579.x, 18284463.
3. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am 2007, 21(3):697-710. viii-ix, 10.1016/j.idc.2007.07.002, 17826619.
4. Cadili A, de Gara C. Complications of splenectomy. Am J Med 2008, 121(5):371-375. 10.1016/j.amjmed.2008.02.014, 18456028.
5. Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am 1996, 10(4):693-707. 10.1016/S0891-5520(05)70322-6, 8958164.
6. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001, 43(3):182-186. 10.1053/jinf.2001.0904, 11798256.
7. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. The British journal of surgery 1991, 78(9):1031-1038. 10.1002/bjs.1800780904, 1933181.
8. Waghorn DJ, Mayon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?. J Infect 1997, 35(3):289-294. 10.1016/S0163-4453(97)93232-1, 9459404.
9. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 2001, 54(3):214-218. 10.1136/jcp.54.3.214, 1731383, 11253134.
10. Wilkes A, Wills V, Smith S. Patient knowledge of the risks of post-splenectomy sepsis. ANZ J Surg 2008, 78(10):867-870. 10.1111/j.1445-2197.2008.04682.x, 18959639.
11. Grace RF, Mednick RE, Neufeld EJ. Compliance with immunizations in splenectomized individuals with hereditary spherocytosis. Pediatr Blood Cancer 2009, 52(7):865-867. 10.1002/pbc.21961, 19214975.
12. Deodhar M, Kakkar N. An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with?. J Clin Pathol 2004, 57(4):407-410. 10.1136/jcp.2003.013896, 1770256, 15047746.
13. Kotsanas D, Al-Souffi MH, Waxman BP, King RW, Polkinghorne KR, Woolley IJ. Adherence to guidelines for prevention of postsplenectomy sepsis. Age and sex are risk factors: a five-year retrospective review. ANZ J Surg 2006, 76(7):542-547. 10.1111/j.1445-2197.2006.03775.x, 16813615.
14. Corbett SM, Rebuck JA, Rogers FB, Callas P, Grindlinger G, Desjardins S, Hebert JC. Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma 2007, 62(2):397-403. 10.1097/01.ta.0000209615.23378.a8, 17297331.
15. Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine 2008, 26(52):6975-6979. 10.1016/j.vaccine.2008.09.052, 18848594.
16. Assy N, Gefen H, Schlesinger S, Karim W. Reactivation versus primary CMV infection after splenectomy in immunocompetent patients. Digestive diseases and sciences 2007, 52(12):3477-3479. 10.1007/s10620-006-9712-1, 17431778.
17. Brydak LB, Machala M, Laguna P, Rokicka-Milewska R. Antibody response to influenza vaccination in splenectomized patients in Poland. Journal of clinical immunology 2004, 24(3):225-236. 10.1023/B:JOCI.0000025444.24160.d5, 15114053.
18. Siber GR, Weitzman SA, Aisenberg AC. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens. Reviews of infectious diseases 1981, 3(Suppl):S144-159.
19. Doganci L, Gun H. Splenectomy and viral vaccines. The Pediatric infectious disease journal 1994, 13(2):163-164. 10.1097/00006454-199402000-00022, 8190548.
20. Shatz DV. Vaccination practices among North American trauma surgeons in splenectomy for trauma. J Trauma 2002, 53(5):950-956. 10.1097/00005373-200211000-00023, 12435949.
21. Landgren O, Bjorkholm M, Konradsen HB, Soderqvist M, Nilsson B, Gustavsson A, Axdorph U, Kalin M, Grimfors G. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. J Intern Med 2004, 255(6):664-673. 10.1111/j.1365-2796.2004.01312.x, 15147530.
22. Cherif H, Landgren O, Konradsen HB, Kalin M, Bjorkholm M. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006, 24(1):75-81. 10.1016/j.vaccine.2005.07.054, 16107293.
23. Eber SW, Langendorfer CM, Ditzig M, Reinhardt D, Stohr G, Soldan W, Schroter W, Tchernia G. Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Ann Hematol 1999, 78(11):524-528. 10.1007/s002770050550, 10602897.
24. Balmer P, Falconer M, McDonald P, Andrews N, Fuller E, Riley C, Kaczmarski E, Borrow R. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 2004, 72(1):332-337. 10.1128/IAI.72.1.332-337.2004, 343978, 14688112.
25. Smets F, Bourgois A, Vermylen C, Brichard B, Slacmuylders P, Leyman S, Sokal E. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine 2007, 25(29):5278-5282. 10.1016/j.vaccine.2007.05.014, 17576024.
26. Mikoluc B, Kayhty H, Bernatowska E, Motkowski R. Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur J Clin Microbiol Infect Dis 2008, 27(10):923-928. 10.1007/s10096-008-0523-5, 18584224.
27. Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, et al. Immune response to pneumococcal conjugate vaccination in asplenic individuals. Human vaccines 2009, 5(2):85-91. 10.4161/hv.5.2.6557, 18758242.
28. Orthopoulos GV, Theodoridou MC, Ladis VA, Tsousis DK, Spoulou VI. The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia. Vaccine 2009, 27(3):350-354. 10.1016/j.vaccine.2008.10.070, 19010369.
29. Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine 2007, 25(29):5390-5398. 10.1016/j.vaccine.2007.04.088, 17583392.
30. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. Mmwr 2005, 54(36):893-897.
31. Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2002, 2(5):440-443.
32. Di Carlo I, Primo S, Pulvirenti E, Toro A. Should all splenectomised patients be vaccinated to avoid OPSI? Revisiting an old concept: an Italian retrospective monocentric study. Hepatogastroenterology 2008, 55(82-83):308-310.
33. Woolley I, Jones P, Spelman D, Gold L. Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic. Aust N Z J Public Health 2006, 30(6):558-561. 10.1111/j.1467-842X.2006.tb00786.x, 17209273.